Pneumonia Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Pneumonia Testing Market is segmented By Type (Consumable and Analyzer), Method Type, Technology, End-User and Geography

Pneumonia Testing Market Snapshot

Pneumonia Testing Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Pneumonia testing market is growing at good rate as pneumonia is a life-threatening disease wherein testing helps the people to know in advance and further, they can be cured quickly. The major factor attributing to the growth of the market are rise in adoption of POC testing and development in the field of nucleic acid detection. Moreover, the awareness level is increasing day by day which results in early diagnosis, hence promoting the growth of pneumonia testing market. 

In addition, pneumonia is found to be the major cause of death in children. For instance, in 2018 according to UNICEF, about 800000 children died due to pneumonia. Also, these diseases are more prevalent in South Asia and African countries. However, due to the limited detection capability and accuracy, the market is expected to be hampered to a certain extent.

Scope of the Report

Pneumonia is a lung disease caused by bacteria, virus and fungi infections in which inflammation in the air sacs, or alveoli is occurred. Pneumonia Testing is segmented By Product Type, Method Type, Technology Type, End User and Geography.

By Product Type
By Method Type
Molecular Diagnostic
Point-of-Care (POC) Testing
By Technology
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunohistochemistry (IHC)
Polymerase Chain Reaction (PCR)
By End-user
Diagnostic Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Point of Care Testing Segment is Expected to Contribute Major Market Share in the Pneumonia Testing Market

  • POC testing is a revolutionary technology which is currently an ideal technique for detecting pneumonia. The growing adoption of POC testing is attributed to higher efficiency, increasing cases of pneumonia and the rapid test results due to which it is highly preferable.
  • Therefore with the high prevalence of chronic diseases in large customer base adopting the cost-effective and immediate diagnostic tests, is propelling the point of care testing. The advantages of POC test to render rapid and accurate results helps in promoting the patient-centred healthcare at bedside settings which further result in the adoption of point of care testing and thereby promoting the growth of pneumonia testing market.
Pneumonia Testing Market

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global Pneumonia Testing due to increasing geriatric population region. For instance, according to Centers for Disease Control and Prevention pneumonia is an eighth leading cause for mortality in the United States which further lead to increased awareness about the disease and further drive the pneumonia testing market. 

There are also rising product approval and increasing product launches that are driving the overall market in this region. For instance, BioMérieux has received FDA Clearance for BioFire's FilmArray Respiratory Panel 2 (RP2). Furthermore, with the increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Pneumonia Testing Market

Competitive Landscape

Pneumonia Testing Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott, Bio-Rad Laboratories, Inc., bioMerieux SA, Thermo Fisher Scientific, Hologic, Inc, Meridian Bioscience, Quidel Corporation, BD and Curetis.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Popularity of POC Testing

      2. 4.2.2 Surge in Awareness Towards Early Diagnosis

      3. 4.2.3 Increase in Government Expenditure on Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Limited Detection Capability and Accuracy

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Consumable

      2. 5.1.2 Analyzer

    2. 5.2 By Method Type

      1. 5.2.1 Immunodiagnostic

      2. 5.2.2 Molecular Diagnostic

      3. 5.2.3 Point-of-Care (POC) Testing

    3. 5.3 By Technology

      1. 5.3.1 Enzyme-Linked Immunosorbent Assay (ELISA)

      2. 5.3.2 Immunofluroscence

      3. 5.3.3 Immunohistochemistry (IHC)

      4. 5.3.4 Polymerase Chain Reaction (PCR)

      5. 5.3.5 Others

    4. 5.4 By End-user

      1. 5.4.1 Hospitals

      2. 5.4.2 Diagnostic Centers

      3. 5.4.3 Others

    5. 5.5 Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Bio-Rad Laboratories, Inc.

      3. 6.1.3 BioMérieux SA

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Curetis

      6. 6.1.6 Hologic Inc.

      7. 6.1.7 Meridian Bioscience

      8. 6.1.8 Thermo Fisher Scientific

      9. 6.1.9 Quidel Corporation

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Pneumonia Testing Market market is studied from 2018 - 2026.

The Pneumonia Testing Market is growing at a CAGR of 8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott, Bio-Rad Laboratories, Inc, bioMerieux SA, Thermo Fisher Scientific, Hologic, Inc are the major companies operating in Pneumonia Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!